MDR And IVDR – Similar Step Ups, Varying Commercial Impacts
Medtech Insight spoke to the CEOs of two companies that recently had very different experiences with the new European IVDR and MDR regulations to gauge their thoughts on any potential commercial impacts.
You may also be interested in...
EU Now Boasts Of 30 Notified Bodies Under The Medical Device Regulation
The landmark figure of 30 notified bodies designated under the MDR has now been reached. But more are needed.
Minute Insight: QuantumDX Launches Panel Test For Flu, COVID-19 And RSV
Medtech Insight spoke to the company’s CEO to find out what the announcement means for QPOC users, and how truly rapid point-of-care testing will aide triage.
Device/Drug Borderline: Gray Areas Remain Despite New EU Guidance
The regulation of products on the drug/device borderline has always been complex. New EU guidance aims to provide clarification, but some difficult and nuanced decision-making is still left to the manufacturer.